日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

抗原特异性免疫治疗药物 AKS-107 可消除胰岛素特异性 B 细胞并预防小鼠自身免疫性糖尿病

David G Alleva, Andrea R Delpero, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Thomas M Lancaster, Mark A Atkinson, Clive H Wasserfall, Liping Yu, Ramya Ragupathy, Rachel H Bonami, Todd C Zion

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

IgG-Fc 融合 COVID-19 亚单位疫苗 AKS-452 的 I/II 期研究的 I 期中期结果

Yester F Janssen, Eline A Feitsma, Hendrikus H Boersma, David G Alleva, Thomas M Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R Delpero, Melanie M Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R Haworth, Nishit J Shah, Vidhya Rao, Shashikant Nagre, Shannon E Ronca, Freedom M Gr

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

IgG-Fc 融合 COVID-19 亚单位疫苗 AKS-452 的开发

David G Alleva, Andrea R Delpero, Melanie M Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K Greaves, Thillainaygam Sathiyaseelan, Jeffrey R Haworth, Nishit J Shah, Vidhya Rao, Shashikant Nagre, Thomas M Lancaster, Sarah S Webb, Allison I Jasa, Shannon E Ronca, Freedom M Green, Hanne Andersen Elya

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100

使用凋亡 DNA 免疫疗法™ (ADi™)、ADi-100 逆转 NOD 小鼠的高血糖症并抑制 1 型糖尿病

David G Alleva, Melika Rezaee, Linda Yip, Gang Ren, Jarrett Rosenberg, Waldo Concepcion, Alan Escher, Shahrokh Shabahang, Avnesh S Thakor

Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)

接种炭疽疫苗吸附加 CPG 7909 (AV7909) 的受试者的早期先天性和 T 细胞介导反应增强

Jacob T Minang, Jon R Inglefield, Andrea M Harris, Janet L Lathey, David G Alleva, Diane L Sweeney, Robert J Hopkins, Michael J Lacy, Edward W Bernton